Original paper
ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP
Abstract
Introduction of the nanobody caplacizumab was shown to be effective in the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in the acute setting. The official recommendations include plasma exchange (PEX), immunosuppression, and the use of caplacizumab for a minimum of 30 days after stopping daily PEX. This study was a retrospective, observational analysis of the use of caplacizumab in 60 patients from 29 medical centers in...
Paper Details
Title
ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP
Published Date
Jul 7, 2020
Journal
Volume
4
Issue
13
Pages
3093 - 3101
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History